| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 108,809 | 102,236 | 99,536 | 83,712 | | Cost of Revenue | 74,244 | 66,615 | 68,680 | 62,124 | | | Gross Profit | 34,565 | 35,621 | 30,856 | 21,588 | | | Operating Expenses | | Research Development | 1,041 | 880 | 814 | 700 | | Selling General and Administrative | 22,400 | 18,044 | 18,065 | 16,308 | | Non Recurring |
-
|
-
| (0) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,124 | 16,697 | 11,978 | 4,580 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,363 | 3,365 | 535 | 334 | | Earnings Before Interest And Taxes | 18,487 | 20,062 | 12,513 | 4,914 | | Interest Expense | 1,191 | 1,331 | 1,208 | 1,219 | | Income Before Tax | 17,296 | 18,731 | 11,305 | 3,695 | | Income Tax Expense | 3,990 | 6,159 | 3,890 | 1,340 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,306 | 12,572 | 7,415 | 2,355 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,306 | 12,572 | 7,415 | 2,355 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,306 | $12,572 | $7,415 | $2,355 |
|
0.15% Nasdaq 
0.01 (0.25%) 
Income Statement
